nach oben

Journal of Parasitic Diseases

Erschienen in:

12.01.2016 | Original Article

Trichomoniasis in older individuals: a preliminary report from Iran

verfasst von: Zohreh Momeni, Javid Sadraei, Bahram Kazemi, Abdolhossein Dalimi

Erschienen in: Journal of Parasitic Diseases | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Infection with Trichomonas vaginalis is one of the most common sexually transmitted diseases (STDs) in humans. The prevalence of infection in Iran has been reported 0.009–8 % depending on deferent socio-cultural conditions. This study aimed to determine the frequency of T. vaginalis according to age in patients referred to clinics, hospitals and medical diagnostic laboratories in Karaj city, Iran. For this purpose, fifty positive samples were collected from July 2012 to June 2014 from clinics, medical diagnostic laboratories and hospitals, then transferred to laboratory of parasitology and cultured in TYM medium. The results showed that all isolates were successfully cultured. Among 50 positive specimens, 43 cases were female and 7 cases male. The most positive cases (34 %) belonged to the ages over 50 year’s group. The lowest positive cases (2 %) belonged to the ages of less than 20 years group. In Conclusion, unlike other STDs, which have a higher prevalence among adolescents and young adults, the rates of trichomoniasis are more evenly distributed among sexually active women of all age groups. However, frequency of this infection in women aged over 50 years (age of menopause) is notable and complementary studies are needed.

Arbabi M, Fakhrieh Z, Delavari M, Abdoli A (2014) Prevalence of Trichomonas vaginalis infection in Kashan city, Iran (2012–2013). Iran J Reprod Med 12(7):507–512PubMedPubMedCentral

Bafghi AF, Aflatoonian A, Barzegar K, Ghafourzadeh M (2009) Frequency distribution of trichomoniasis in pregnant women referred to health centers of Ardakan, Meibod and Yazd, Iran. Jundishapur J Microbiol 2(4):132–139

Bakhtiari A, Hajian-Tilaki K, Pasha H (2008) Genital infection by Trichomonas vaginalis in women referring to Babol health centers: prevalence and risk factors. IRCMJ 10(1):16–21

Bowden FJ, Garnett GP (2000) Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex Transm Infect 76:248–256CrossRefPubMedPubMedCentral

Calvet HM (2003) Sexually transmitted diseases other than human immunodeficiency virus infection in older adults. Clin Infect Dis 36:609–614CrossRefPubMed

Cherpes TL, Wiesenfeld HC, Melan MA, Kant JA, Cosentino LA, Meyn LA et al (2006) The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 33(12):747–752CrossRefPubMed

Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH et al (1997) Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 24(6):353–360CrossRefPubMed

Cudmore SL, Delgaty KL, Shannon F, Petrin DP, Garber GE, Hayward-McClelland SF et al (2004) Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 17(4):783–793CrossRefPubMedPubMedCentral

Depuydt CE, Leuridan E, Van Damme P, Bogers J, Vereecken AJ, Donders GGG (2010) Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders. Gynecol Obstet Invest 70(4):273–280CrossRefPubMed

Diamond LS (1957) The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol 43(4):488–490CrossRefPubMed

Donders GGG, Depuydt C, Letter C (2013) Increased prevalence of Trichomonas vaginalis in mid-aged women is linked to sexual activity and not to hormonal changes. J Low Genit Tract Dis 17(4):1–2CrossRef

Dunn ME, Cutler N (2000) Sexual issues in older adults. AIDS Patient Care STDS 14(2):67–69CrossRefPubMed

Figueroa-Angulo EE, Rendón-Gandarilla FJ, Puente-rivera J, Calla-Choque JS, Cárdenas-Guerra RE, Ortega-López J et al (2012) The effects of environmental factors on the virulence of Trichomonas vaginalis. Microb Infect 14(15):1411–1427CrossRef

Gavgani A-SM, Namazi A, Ghazanchaei A, Alizadeh S, Sehhati F, Rostamzadeh S et al (2008) Prevalence and risk factors of trichomoniasis among women in Tabriz. Iran J Clinic Infect Dis 3(2):67–71

Harp DF, Chowdhury I (2011) Trichomoniasis: evaluation to execution. Eur J Obstet Gynecol Reprod Biol 157:3–9CrossRefPubMedPubMedCentral

Hezarjaribi HZ, Fakhar M, Shokri A (2015) Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis. Parasitol Res 114:1291–1300CrossRefPubMed

Hobbs M, Sena A, Swygard H, Schwebke JR (2008) Trichomonas vaginalis and trichomoniasis. In: Holmes K, Sparling P, Stamm W (eds) Sexually Transmitted Diseases. McGraw Hill, New York, pp 771–794

Krieger JN, Rein MF (1982) Zinc sensitivity of Trichomonas vaginalis: in vitro studies and clinical implications. J Infect Dis 146(3):341–345CrossRefPubMed

Lazenby GB, Taylor PT, Badman BS, Mchaki E, Korte JE, Soper DE et al (2014) An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther 36(1):38–45CrossRefPubMed

Lusk MJ, Naing Z, Rayner B, Rismanto N, McIver CJ, Cumming RG et al (2010) Trichomonas vaginalis: underdiagnosis in urban Australia could facilitate re-emergence. Sex Transm Infect 86(3):227–230CrossRefPubMed

Matini M, Rezaie S, Mohebali M, Rabiee S, Fallah M, Rezaeian M (2012) Prevalence of Trichomonas vaginalis infection in Hamadan City, Western Iran. Iran J Parasitol 7(2):67–72PubMedPubMedCentral

McClelland RS, Sangaré L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J et al (2007) Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195(5):698–702CrossRefPubMed

Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W et al (1984) Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 150(8):965–972CrossRefPubMed

Munson E, Kramme T, Napierala M, Munson KL, Miller C, Hryciuk JE (2012) Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection. J Clin Microbiol 50(12):3927–3931CrossRefPubMedPubMedCentral

Munson KL, Napierala M, Munson E, Schell RF, Kramme T, Miller C, Hryciuk JE (2013) Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection. J Clin Microbiol 51:101–104CrossRefPubMedPubMedCentral

Nourian A, Shabani N, Fazaeli A, Mousavinasab SN (2013) Prevalence of Trichomonas vaginalis in pregnant women in Zanjan, Northwest of Iran. Jundishapur J Microbiol 6(8):e7258CrossRef

Petrin D, Delgaty K, Bhatt R, Garber G (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11(2):300–317PubMedPubMedCentral

Poole DN, McClelland RS (2013) Global epidemiology of Trichomonas vaginalis. Sex Transm Dis 89(6):418–422CrossRef

Poynten IM, Poynten IM, Grulich AE, Templeton DJ (2013) Sexually transmitted infections in older populations. Curr Opin Infect Dis 26:80–85CrossRefPubMed

Rezaeian M, Vatanshenassan M, Rezaie S, Mohebali M, Niromand N, Niyyati M et al (2009) Prevalence of Trichomonas vaginalis using parasitological methods in Tehran. Iran J Parasitol 4(4):43–47

Rowley J, Toskin I, Ndowa F (2012) Global incidence and prevalence of selected curable sexually transmitted infections—2008. World Health Organization, Geneva, pp 1–20

Sharma R, Pickering J, McCormack WM (1997) Trichomoniasis in a postmenopausal woman cured after discontinuation of estrogen replacement therapy. Sex Transm Dis 24(9):543–545CrossRefPubMed

Spinillo A, Bernuzzi AM, Cevini C, Gulminetti R, Luzi S, De Santolo A (1997) The relationship of bacterial vaginosis, Candida and Trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic. Maturitas 27(3):253–260CrossRefPubMed

Stemmer SM, Adelson ME, Trama JP, Dorak MT, Mordechai E (2012) Detection rates of Trichomonas vaginalis, in different age groups, using real-time polymerase chain reaction. J Low Genit Tract Dis 16(4):352–357CrossRefPubMed

Twu O, Dessí D, Vu A, Mercer F, Stevens GC, De Miguel N et al (2014) Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. PNAS 111(22):8179–8184CrossRefPubMedPubMedCentral

Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen P-L et al (2008) Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197(4):548–554CrossRef

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2013) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163–2196CrossRef

Titel: Trichomoniasis in older individuals: a preliminary report from Iran
verfasst von: Zohreh Momeni
Javid Sadraei
Bahram Kazemi
Abdolhossein Dalimi
Publikationsdatum: 12.01.2016
Verlag: Springer India
Erschienen in: Journal of Parasitic Diseases / Ausgabe 4/2016
Print ISSN: 0971-7196
Elektronische ISSN: 0975-0703
DOI: https://doi.org/10.1007/s12639-015-0737-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Trichomoniasis in older individuals: a preliminary report from Iran

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Prevalence of hypodermosis in cattle slaughtered in industrial slaughtered-house of Ardebil, Iran

A rare cause of dysphagia: pharyngeal ascariasis

Diagnosis and therapeutic management of Dipylidium caninum in dogs: a case report

Zataria multiflora Bioss: lethal effects of methanolic extract against protoscoleces of Echinococcus granulosus

The common zoonotic protozoal diseases causing abortion

Prevalence and seasonal variation of ectoparasites in cultured Nile tilapia Oreochromis niloticus in Saudi Arabia

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin